Letters Pfizer and pregabalin Pregabalin is only partially effective for neuropathic pain BMJ 2015; 350 doi: https://doi.org/10.1136/bmj.h3478 (Published 30 June 2015) Cite this as: BMJ 2015;350:h3478 Article Related content Metrics Responses Peer review Related articles Feature Pfizer steps up battle to defend control of pregabalin Published: 08 June 2015; BMJ 350 doi:10.1136/bmj.h3119 See more An adolescent with disabling abdominal pain BMJ December 07, 2016, 355 i6101; DOI: https://doi.org/10.1136/bmj.i6101 What it feels like to be an interesting teaching opportunity BMJ December 07, 2016, 355 i6190; DOI: https://doi.org/10.1136/bmj.i6190 Johnson & Johnson is ordered to pay $1bn over faulty hip implants BMJ December 06, 2016, 355 i6551; DOI: https://doi.org/10.1136/bmj.i6551 Shared decision making in patients with low risk chest pain: prospective randomized pragmatic trial BMJ December 05, 2016, 355 i6165; DOI: https://doi.org/10.1136/bmj.i6165 Generics have a chequered recent history BMJ December 05, 2016, 355 i6527; DOI: https://doi.org/10.1136/bmj.i6527
